Guide to Biotechnology 2008

Total Page:16

File Type:pdf, Size:1020Kb

Guide to Biotechnology 2008 guide to biotechnology 2008 research & development health bioethics innovate industrial & environmental food & agriculture biodefense Biotechnology Industry Organization 1201 Maryland Avenue, SW imagine Suite 900 Washington, DC 20024 intellectual property 202.962.9200 (phone) 202.488.6301 (fax) bio.org inform bio.org The Guide to Biotechnology is compiled by the Biotechnology Industry Organization (BIO) Editors Roxanna Guilford-Blake Debbie Strickland Contributors BIO Staff table of Contents Biotechnology: A Collection of Technologies 1 Regenerative Medicine ................................................. 36 What Is Biotechnology? .................................................. 1 Vaccines ....................................................................... 37 Cells and Biological Molecules ........................................ 1 Plant-Made Pharmaceuticals ........................................ 37 Therapeutic Development Overview .............................. 38 Biotechnology Industry Facts 2 Market Capitalization, 1994–2006 .................................. 3 Agricultural Production Applications 41 U.S. Biotech Industry Statistics: 1995–2006 ................... 3 Crop Biotechnology ...................................................... 41 U.S. Public Companies by Region, 2006 ........................ 4 Forest Biotechnology .................................................... 44 Total Financing, 1998–2007 (in billions of U.S. dollars) .... 4 Animal Biotechnology ................................................... 45 Biotech Industry Financing .............................................. 5 Aquaculture .................................................................. 51 Global Area of Transgenic Crops, 1995–2007: Industrial Time Line 6 and Developing Countries (million acres) .................. 53 Biotechnology Policy Milestones ................................... 15 Global Area of Transgenic Crops in 2006 and 2007 by Country (million acres)............. 53 Technologies and Tools 18 Bioprocessing Technology ............................................ 18 Agricultural Biotech Products on the Market 54 Recombinant DNA Technology ..................................... 18 Food Biotechnology 60 Monoclonal Antibodies ................................................. 19 Improving the Raw Materials ......................................... 60 Cloning ......................................................................... 20 Food Processing .......................................................... 61 Protein Engineering ....................................................... 20 Food Safety Testing ...................................................... 62 Biosensors ................................................................... 21 Nanobiotechnology ...................................................... 21 Industrial and Environmental Applications 63 Microarrays ................................................................... 22 Industrial Sustainability .................................................. 63 Biocatalysts .................................................................. 64 From Biotechnology to Biology: Using Biotech Biofuel .......................................................................... 64 Tools to Understand Life 23 Research Applications of Biotechnology ....................... 23 Existing and Planned U.S. Cellulosic Ethanol Biorefineries .................................................. 66 Putting the Pieces Together: ‘Omics’ and Related Tools .... 27 Green Plastics .............................................................. 67 The Next Step: Using New Knowledge to Develop Products ................................................ 29 Nanotechnology ........................................................... 67 Environmental Biotechnology ........................................ 68 Health Care Applications 32 Industries That Benefit .................................................. 69 Diagnostics ................................................................... 32 Therapeutics ................................................................. 32 Consumer Goods Made With Industrial Biotech 70 Personalized Medicine .................................................. 35 Examples of Industrial Enzymes 71 Biotechnology Industry Organization i Industrial Biotech–Related Sales in Patenting Organisms .................................................... 79 Chemicals, 2005: $95.5 Billion 72 Patent Licensing ........................................................... 80 Recent Patent Developments ....................................... 80 Preparedness for Pandemics and Biodefense 73 A Strategic Asset .......................................................... 73 Ethics 81 Other Approaches ........................................................ 74 Ethical Issues ................................................................ 82 Other Uses 75 BIO Statement of Ethical Principles 86 DNA Fingerprinting ....................................................... 75 Biotechnology Resources 88 Intellectual Property 77 Periodicals, Headline Services and Web Sites ...........88 What Is a Patent? ......................................................... 77 General Science Journals ............................................. 89 The Purpose of a Patent ............................................... 77 Biotech Education and Careers .................................... 89 Patentable Inventions ...............................................78 Selected Recent Reports on Biotechnology .................. 89 Patent Requirements .................................................... 78 The Patent Application .................................................. 79 Glossary of Biotech-related Terms 93 ii Guide to Biotechnology biotechnology: A Collection of Technologies What Is Biotechnology? person’s body has the same DNA. Most DNA is located in the cell nucleus (where it is called nuclear DNA), but a small amount of At its simplest, biotechnology is technology based on biology. From DNA can also be found in another part of the cell called the mito- that perspective, the use of biological processes is hardly noteworthy. chondria (mitochondrial DNA or mtDNA). We began growing crops and raising animals 10,000 years ago to The information in DNA is stored as a code made up of four chemical provide a stable supply of food and clothing. We have used the biologi- bases: adenine (A), guanine (G), cytosine (C) and thymine (T). Hu- cal processes of microorganisms for 6,000 years to make useful food man DNA consists of about 3 billion bases, and more than 99 percent products, such as bread and cheese, and to preserve dairy products. of those bases are the same in all people. The order, or sequence, of Crops? Cheese? That doesn’t sound very exciting. So why does these bases determines the information available for building and biotechnology receive so much attention? maintaining an organism, similar to the way in which letters of the alphabet appear in a certain order to form words and sentences. No The answer is that in the last 40 years we’ve gone from practicing two people, except for identical twins, share the exact same DNA biotechnology at a macro level—breeding animals and crops, for sequences. example—to working with it at a micro level. It was during the 1960s and ’70s that our understanding of biology reached a point DNA bases pair up with each other, A with T and C with G, to form where we could begin to use the smallest parts of organisms—the units called base pairs. Each base is also attached to a sugar molecule biological molecules of which they are composed—in addition to and a phosphate molecule. Together, a base, sugar, and phosphate using whole organisms. are called a nucleotide. Nucleotides are arranged in two long strands that form a spiral called a double helix. Long, continuous strands of An appropriate modern definition of biotechnology would be DNA are organized into chromosomes. Human cells (except for the “the use of cellular and biomolecular processes to solve prob- sex, or germ, cells) have 46 chromosomes, arranged in 23 pairs. Half lems or make useful products.” come from the mother, half from the father. We can get a better handle on the meaning of the wordbiotechnol - Specific sections of DNA that carry the code for particular proteins are ogy by thinking of it in its plural form, biotechnologies. That’s because called genes. When a particular protein is needed, the DNA base pairs biotechnology is a collection of technologies that capitalize on the split, and RNA (ribonucleic acid) bases attach to the open DNA bases, attributes of cells, such as their manufacturing capabilities, and put forming a strand of mRNA (messenger RNA). The mRNA travels to biological molecules, such as DNA and proteins, to work for us. other parts of the cell where the sequence of the mRNA is “read” by other cell structures that make the protein. Cells and Biological Molecules The NIH provides a well-illustrated primer on DNA and genetics, Help Me Understand Genetics. You can download it at http://ghr. Cells are the basic building blocks of all living things. The simplest nlm.nih.gov/. living things, such as yeast, consist of a single, self-sufficient cell. Com- plex creatures more familiar to us, such as plants, animals and humans, WHY IS DNA THE CORNERSTONE OF BIOTECHNOLOGY? are made of many different cell types, each of which performs very Because virtually all cells speak the same genetic language, DNA from
Recommended publications
  • Nanotechnology in Drug Delivery: the Need for More Cell Culture Based
    Kura et al. Chemistry Central Journal 2014, 8:46 http://journal.chemistrycentral.com/content/8/1/46 MINI REVIEW Open Access Nanotechnology in drug delivery: the need for more cell culture based studies in screening Aminu Umar Kura1, Sharida Fakurazi1,2*, Mohd Zobir Hussein3 and Palanisamy Arulselvan1 Abstract Advances in biomedical science are leading to upsurge synthesis of nanodelivery systems for drug delivery. The systems were characterized by controlled, targeted and sustained drug delivery ability. Humans are the target of these systems, hence, animals whose systems resembles humans were used to predict outcome. Thus, increasing costs in money and time, plus ethical concerns over animal usage. However, with consideration and planning in experimental conditions, in vitro pharmacological studies of the nanodelivery can mimic the in vivo system. This can function as a simple method to investigate the effect of such materials without endangering animals especially at screening phase. Keywords: In vitro, Animal studies, Nanodelivery system, Toxicity and bio distribution Introduction However, with changes and improvement in drug de- Nanodelivery system (NDS) is a branch of Nanomedicine livery via NDS comes a price (possible toxic effect), the characterized by controlled, targeted and sustained drug evaluation of which is important before any biological delivery ability, a limitation and drawback that is currently application can be introduce. In 2004, the term nanotoxi- limiting conventional drug delivery system especially city was coined; referring to the study of the potential in drug delivery to tight areas like the brain [1]. NDS, toxic impacts of nanoparticles on biological and ecological due to their small sizes usually below 100 nm and systems [5].
    [Show full text]
  • Food Produced Using Animal Cell Culture Technology (07/12/2018) Page 1
    Food Produced Using Animal Cell Culture Technology (07/12/2018) Page 1 U.S. FOOD & DRUG ADMINISTRATION OFFICE OF FOODS AND VETERINARY MEDICINE CENTER FOR FOOD SAFETY & APPLIED NUTRITION FDA Public Meeting: Foods Produced Using Animal Cell Culture Technology Docket No. FDA-2018-N-2155 Harvey W. Wiley Federal Building - Auditorium 5001 Campus Drive College Park, MD 20740 Thursday, July 12, 2018 Reported by: Natalia Thomas, Capital Reporting Company Food Produced Using Animal Cell Culture Technology (07/12/2018) Page 2 A P P E A R A N C E S Jessica Almy The Good Food Institute Kari Barrett Advisor for Strategic Communications and Public Engagement, Office of Food and Veterinary Medicine, FDA Danielle Beck National Cattlemen's Beef Association Dustin Boler, PhD American Meat Science Association Benjamina Bollag Higher Steaks Beth Briczinski, PhD National Milk Producers Federation Lou Cooperhouse BlueNalu Isha Datar Executive Director, New Harvest Jeremiah Fasano Consumer Safety Officer, Division of Biotechnology and GRAS Notice Review, Office of Food Additive Food Produced Using Animal Cell Culture Technology (07/12/2018) Page 3 A P P E A R A N C E S Safety, Center for Food Safety and Applied Nutrition, FDA Scott Gottlieb, MD Commissioner, FDA Michael Hansen, PhD Consumers Union Gregory Jaffe Director, Project on Biotechnology, Center for Science in the Public Interest William Jones, PhD Acting Director, Office of Food Safety, Center for Food Safety and Applied Nutrition, FDA Kate Krueger, PhD New Harvest Tiffany Lee, DVM North American Meat Institute Peter Licari Chief Technology Officer, JUST Susan Mayne, PhD Director, Center for Food Safety and Applied Nutrition, FDA Food Produced Using Animal Cell Culture Technology (07/12/2018) Page 4 A P P E A R A N C E S Paul McCright, PhD Biotrack Diagnostics, Inc.
    [Show full text]
  • A Caspase-1 Biosensor to Monitor the Progression of Inflammation in Vivo
    Published October 2, 2019, doi:10.4049/jimmunol.1900619 The Journal of Immunology A Caspase-1 Biosensor to Monitor the Progression of Inflammation In Vivo Sarah Talley,* Olga Kalinina,† Michael Winek,‡ Wonbeom Paik,† Abigail R. Cannon,* Francis Alonzo, III,† Mashkoor A. Choudhry,* Katherine L. Knight,† and Edward M. Campbell*,†,‡ Inflammasomes are multiprotein complexes that coordinate cellular inflammatory responses and mediate host defense. Following recognition of pathogens and danger signals, inflammasomes assemble and recruit and activate caspase-1, the cysteine protease that cleaves numerous downstream targets, including pro–IL-1b and pro–IL-18 into their biologically active form. In this study, we sought to develop a biosensor that would allow us to monitor the initiation, progression, and resolution of inflammation in living animals. To this end, we inserted a known caspase-1 target sequence into a circularly permuted luciferase construct that becomes bioluminescent upon protease cleavage. This biosensor was activated in response to various inflammatory stimuli in human monocytic cell lines and murine bone marrow–derived macrophages. Next, we generated C57BL/6 transgenic mice constitutively expressing the caspase-1 biosensor. We were able to monitor the spatiotemporal dynamics of caspase-1 activation and onset of inflammation in individual animals in the context of a systemic bacterial infection, colitis, and acute graft-versus-host disease. These data established a model whereby the development and progression of inflammatory responses can be monitored in the context of these and other mouse models of disease. The Journal of Immunology, 2019, 203: 000–000. umerous cell types, canonically cells of the innate im- filamentous complexes, providing a platform for the recruitment mune system, express cytosolic, nuclear, and membrane- and subsequent activation of caspase-1 (1–4, 8, 10–15).
    [Show full text]
  • Career Guide Biological Sciences Concentration in Microbiology
    MAJOR TO BACHELOR OF SCIENCE IN CAREER GUIDE BIOLOGICAL SCIENCES CONCENTRATION IN MICROBIOLOGY Majoring in biological sciences with a concentration in microbiology provides students with intellectual and technical skills required for success in the broad area of microbiology, which includes clinical, environmental, ecological, evolutionary, molecular, metabolic, and physiological perspectives of microbes, including aspects of virology and immunology. Students concentrating in microbiology should also be able to explain the diversity and ABOUT THE MAJOR/ similarity of microbes, including their physiology, mechanisms of pathogenesis and host CONCENTRATION defenses, and unique ecology. SKILLS Research Problem-Solving Ability to Operate Critical Thinking Scientific Equipment Agricultural and Food Scientist Environmental Scientist Quality Control Analyst Bacteriologist Lab Technician* Regulatory Affairs Specialist Biomedical Scientist* Medical Device Specialist Research Microbiologist Biotechnologist* Mycologist Science Educator* Cell Biologist Parasitologists Virologist POTENTIAL CAREER Clinical Microbiologist Public Health Professional OPPORTUNITIES *Additional education/certification may be required COMMON CAREER AREAS FOR THIS MAJOR Organismal/ Research & Biomedical Healthcare Ecological Education Biotechnology Bioinformatics Development Sciences Biology Do volunteer work Get part-time job or internship Did you know UNLV has programs, student A part-time, temporary, and summer job or groups, and academic service-learning internship can
    [Show full text]
  • Observation and a Numerical Study of Gravity Waves During Tropical Cyclone Ivan (2008)
    Open Access Atmos. Chem. Phys., 14, 641–658, 2014 Atmospheric www.atmos-chem-phys.net/14/641/2014/ doi:10.5194/acp-14-641-2014 Chemistry © Author(s) 2014. CC Attribution 3.0 License. and Physics Observation and a numerical study of gravity waves during tropical cyclone Ivan (2008) F. Chane Ming1, C. Ibrahim1, C. Barthe1, S. Jolivet2, P. Keckhut3, Y.-A. Liou4, and Y. Kuleshov5,6 1Université de la Réunion, Laboratoire de l’Atmosphère et des Cyclones, UMR8105, CNRS-Météo France-Université, La Réunion, France 2Singapore Delft Water Alliance, National University of Singapore, Singapore, Singapore 3Laboratoire Atmosphères, Milieux, Observations Spatiales, UMR8190, Institut Pierre-Simon Laplace, Université Versailles-Saint Quentin, Guyancourt, France 4Center for Space and Remote Sensing Research, National Central University, Chung-Li 3200, Taiwan 5National Climate Centre, Bureau of Meteorology, Melbourne, Australia 6School of Mathematical and Geospatial Sciences, Royal Melbourne Institute of Technology (RMIT) University, Melbourne, Australia Correspondence to: F. Chane Ming ([email protected]) Received: 3 December 2012 – Published in Atmos. Chem. Phys. Discuss.: 24 April 2013 Revised: 21 November 2013 – Accepted: 2 December 2013 – Published: 22 January 2014 Abstract. Gravity waves (GWs) with horizontal wavelengths ber 1 vortex Rossby wave is suggested as a source of domi- of 32–2000 km are investigated during tropical cyclone (TC) nant inertia GW with horizontal wavelengths of 400–800 km, Ivan (2008) in the southwest Indian Ocean in the upper tropo- while shorter scale modes (100–200 km) located at northeast sphere (UT) and the lower stratosphere (LS) using observa- and southeast of the TC could be attributed to strong local- tional data sets, radiosonde and GPS radio occultation data, ized convection in spiral bands resulting from wave number 2 ECMWF analyses and simulations of the French numerical vortex Rossby waves.
    [Show full text]
  • Integrated Pest Management: Current and Future Strategies
    Integrated Pest Management: Current and Future Strategies Council for Agricultural Science and Technology, Ames, Iowa, USA Printed in the United States of America Cover design by Lynn Ekblad, Different Angles, Ames, Iowa Graphics and layout by Richard Beachler, Instructional Technology Center, Iowa State University, Ames ISBN 1-887383-23-9 ISSN 0194-4088 06 05 04 03 4 3 2 1 Library of Congress Cataloging–in–Publication Data Integrated Pest Management: Current and Future Strategies. p. cm. -- (Task force report, ISSN 0194-4088 ; no. 140) Includes bibliographical references and index. ISBN 1-887383-23-9 (alk. paper) 1. Pests--Integrated control. I. Council for Agricultural Science and Technology. II. Series: Task force report (Council for Agricultural Science and Technology) ; no. 140. SB950.I4573 2003 632'.9--dc21 2003006389 Task Force Report No. 140 June 2003 Council for Agricultural Science and Technology Ames, Iowa, USA Task Force Members Kenneth R. Barker (Chair), Department of Plant Pathology, North Carolina State University, Raleigh Esther Day, American Farmland Trust, DeKalb, Illinois Timothy J. Gibb, Department of Entomology, Purdue University, West Lafayette, Indiana Maud A. Hinchee, ArborGen, Summerville, South Carolina Nancy C. Hinkle, Department of Entomology, University of Georgia, Athens Barry J. Jacobsen, Department of Plant Sciences and Plant Pathology, Montana State University, Bozeman James Knight, Department of Animal and Range Science, Montana State University, Bozeman Kenneth A. Langeland, Department of Agronomy, University of Florida, Institute of Food and Agricultural Sciences, Gainesville Evan Nebeker, Department of Entomology and Plant Pathology, Mississippi State University, Mississippi State David A. Rosenberger, Plant Pathology Department, Cornell University–Hudson Valley Laboratory, High- land, New York Donald P.
    [Show full text]
  • An Instrumented Centrifuge for Studying Mouse Locomotion and Behaviour Under Hypergravity Benjamin J
    © 2019. Published by The Company of Biologists Ltd | Biology Open (2019) 8, bio043018. doi:10.1242/bio.043018 METHODS AND TECHNIQUES An instrumented centrifuge for studying mouse locomotion and behaviour under hypergravity Benjamin J. H. Smith* and James R. Usherwood ABSTRACT (Alexander, 1984). Investigating the limitations of inverted Gravity may influence multiple aspects of legged locomotion, from the pendulum models of locomotion may lead to advances in robotics periods of limbs moving as pendulums to the muscle forces required and treatment of gait pathologies, as well as our fundamental to support the body. We present a system for exposing mice to understanding of legged locomotion. hypergravity using a centrifuge and studying their locomotion and The motion of an inverted pendulum can be described using u€ ¼ g u u€ activity during exposure. Centrifuge-induced hypergravity has the the equation L sin , where is angular acceleration, g is θ advantages that it both allows animals to move freely, and it affects gravitational acceleration, L is length, and is angular displacement both body and limbs. The centrifuge can impose two levels of from the equilibrium point; testing the predictions of inverted hypergravity concurrently, using two sets of arms of different lengths, pendulum-based models therefore requires the manipulation of either each carrying a mouse cage outfitted with a force and speed L or g. Differences in L are usually studied by comparing similar measuring exercise wheel and an infrared high-speed camera; both animals of different sizes (Gatesy and Biewener, 1991; Daley and triggered automatically when a mouse begins running on the wheel.
    [Show full text]
  • Detection of Dna Hybridization on a Configurable Digital Microfluidic
    DETECTION OF DNA HYBRIDIZATION ON A CONFIGURABLE DIGITAL MICROFLUIDIC BIO- CHIP USING SPR IMAGING Lidija Malic1, Teodor Veres2 and Maryam Tabrizian1 1Biomedical Engineering Department, McGill University, CANADA and 2Industrial Materials Institute, National Research Council, CANADA ABSTRACT This paper presents a configurable digital microfluidic-based surface plasmon resonance (SPR) biochip platform comprising an electrowetting-on-dielectric (EWOD) microfluidic device coupled to SPR imaging (SPRi). We demonstrate its application for dynamic on-chip simultaneous immobilization of different DNA probes in combination with multichannel label-free real-time detection of subse- quent hybridization reactions. The integrated EWOD-SPRi system would enable the development of high-throughput, rapid and ultrasensitive biomolecular detection strategies beyond DNA microarray applications. KEYWORDS: Digital microfluidics, EWOD, SPR imaging, DNA hybridization INTRODUCTION EWOD microfluidics has attracted considerable attention in the past decade and the most recent efforts are directed towards its application in biomedical research [1- 3]. While these studies demonstrate the versatility of EWOD devices, the reported applications involve homogeneous phase reactions [4] and detection methods that require labeled biomolecules [2] or sample extraction from the chip [1]. This in- creases both the time and complexity of the assay. To introduce new applications relying on label-free, real-time surface sensitive detection techniques such as SPRi, it would be advantageous to use droplet-based EWOD actuation for surface specific biomolecule immobilization. However, the need of hydrophobic properties for EWOD actuation renders immobilization of biomolecules such as DNA on the sur- face of the chip impossible [3, 4]. In this paper, we demonstrate for the first time the use of an EWOD microfluidic chip to dynamically immobilize DNA probes in a two-dimensional array, followed by SPRi detection of bioaffinity interactions.
    [Show full text]
  • Dolly the Sheep – the First Cloned Adult Animal
    DOLLY THE SHEEP – THE FIRST CLONED ADULT ANIMAL NEW TECHNOLOGY FOR IMPROVING LIVESTOCK From Squidonius via Wikimedia Commons In 1996, University of Edinburgh scientists celebrated the birth of Dolly the Sheep, the first mammal to be cloned using SCNT cloning is the only technology adult somatic cells. The Edinburgh team’s success followed available that enables generation of 99.8% its improvements to the single cell nuclear transfer (SCNT) genetically identical offspring from selected technique used in the cloning process. individuals of adult animals (including sterilized animals). As such, it is being Dolly became a scientific icon recognised worldwide and exploited as an efficient multiplication tool SCNT technology has spread around the world and has been to support specific breeding strategies of used to clone multiple farm animals. farm animals with exceptionally high genetic The cloning of livestock enables growing large quantities of value. the most productive, disease resistant animals, thus providing more food and other animal products. Sir Ian Wilmut (Inaugural Director of MRC Centre for Regeneration and Professor at CMVM, UoE) and colleagues worked on methods to create genetically improved livestock by manipulation of stem cells using nuclear transfer. Their research optimised interactions between the donor nucleus and the recipient cytoplasm at the time of fusion and during the first cell cycle. Nuclear donor cells were held in mitosis before being released and used as they were expected to be passing through G1 phase. CLONING IN COMMERCE, CONSERVATION OF AGRICULTURE AND PRESERVATION ANIMAL BREEDS OF LIVESTOCK DIVERSITY Cloning has been used to conserve several animal breeds in the recent past.
    [Show full text]
  • PHYSICS of ARTIFICIAL GRAVITY Angie Bukley1, William Paloski,2 and Gilles Clément1,3
    Chapter 2 PHYSICS OF ARTIFICIAL GRAVITY Angie Bukley1, William Paloski,2 and Gilles Clément1,3 1 Ohio University, Athens, Ohio, USA 2 NASA Johnson Space Center, Houston, Texas, USA 3 Centre National de la Recherche Scientifique, Toulouse, France This chapter discusses potential technologies for achieving artificial gravity in a space vehicle. We begin with a series of definitions and a general description of the rotational dynamics behind the forces ultimately exerted on the human body during centrifugation, such as gravity level, gravity gradient, and Coriolis force. Human factors considerations and comfort limits associated with a rotating environment are then discussed. Finally, engineering options for designing space vehicles with artificial gravity are presented. Figure 2-01. Artist's concept of one of NASA early (1962) concepts for a manned space station with artificial gravity: a self- inflating 22-m-diameter rotating hexagon. Photo courtesy of NASA. 1 ARTIFICIAL GRAVITY: WHAT IS IT? 1.1 Definition Artificial gravity is defined in this book as the simulation of gravitational forces aboard a space vehicle in free fall (in orbit) or in transit to another planet. Throughout this book, the term artificial gravity is reserved for a spinning spacecraft or a centrifuge within the spacecraft such that a gravity-like force results. One should understand that artificial gravity is not gravity at all. Rather, it is an inertial force that is indistinguishable from normal gravity experience on Earth in terms of its action on any mass. A centrifugal force proportional to the mass that is being accelerated centripetally in a rotating device is experienced rather than a gravitational pull.
    [Show full text]
  • Combatting Monsanto
    Picture: Grassroots International Combatting Monsanto Grassroots resistance to the corporate power of agribusiness in the era of the ‘green economy’ and a changing climate La Via Campesina, Friends of the Earth International, Combat Monsanto Technical data name: “Combatting Monsanto Grassroots resistance to the corporate power of agribusiness in the era of the ‘green economy’ and a changing climate” author: Joseph Zacune ([email protected]) with contributions from activists around the world editing: Ronnie Hall ([email protected]) design and layout: Nicolás Medina – REDES-FoE Uruguay March 2012 Combatting Monsanto Grassroots resistance to the corporate power of agribusiness in the era of the ‘green economy’ and a changing climate INDEX Executive summary / 2 Company profile - Monsanto / 3 Opposition to Monsanto in Europe / 5 A decade of French resistance to GMOs / 6 Spanish movements against GM crops / 9 German farmers’ movement for GM-free regions / 10 Organising a movement for food sovereignty in Europe / 10 Monsanto, Quit India! / 11 Bt brinjal and biopiracy / 11 Bt cotton dominates cotton sector / 12 Spiralling debt still triggering suicides / 12 Stopping Monsanto’s new public-private partnerships / 13 Resistance to Monsanto in Latin America / 14 Brazilian peasant farmers’ movement against agribusiness / 14 Ten-year moratorium on GM in Peru / 15 Landmark ruling on toxic soy in Argentina / 15 Haitians oppose seed aid / 16 Guatemalan networks warn of new biosafety proposals / 17 Battle-lines drawn in the United States / 17 Stopping the
    [Show full text]
  • The Future for Biosensors in Biopharmaceutical Production
    Pharmaceutical Commentary BRACEWELL & POLIZZI The future for biosensors in biopharmaceutical production 2 Commentary The future for biosensors in biopharmaceutical production Pharm. Bioprocess. Keywords: bioprocess monitoring • bioprocess control • in-vivo biosensor • PAT Daniel G Bracewell*,1 • synthetic biology & Karen M Polizzi2 1The Advanced Centre for Biochemical Engineering, Department of Biochemical A defining feature of bioprocesses is the need straightforward. This is not to say there have Engineering, University College London, for measurement, monitoring and control; in not been significant successes: Torrington Place, London, WC1E 7JE, UK the context of biopharmaceuticals this need 2Department of Life Sciences & Centre • The world’s diabetic population depends is further heightened by the absolute require- for Synthetic Biology & Innovation, on blood glucose measurements to admin- Imperial College London, London, UK ment to ensure the quality of the product [1] . ister insulin based on an amperometric *Author for correspondence: This is evidenced by the size of bioanalytical based biosensor technology (enzyme elec- [email protected] endeavor found within the R&D programs trodes). This represents the largest single of the major biopharmaceutical companies biosensor application in terms of numbers and the supplier industry that caters for this of devices and market size; instrumentation need. It is a need that grows at a pace reflected in the initiatives involv- • Optical biosensors, largely surface plas- ing the regulatory authorities such as PAT mon resonance (BIAcore) has become central to the larger vision of QbD. At the the default method to directly mea- core of these attempts to improve biophar- sure protein–protein interactions in the maceutical production is the need for rapid, laboratory.
    [Show full text]